ReviewJournal of thoracic disease2013
Screening for lung cancer with low-dose computed tomography: a review of current status.
Review in Journal of thoracic disease, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.Journal of the National Comprehensive Cancer Network : JNCCN · 2018Guideline
- ESR/ERS white paper on lung cancer screening.European radiology · 2015Guideline
- Diagnostic value of computed tomography scanning in differentiating malignant from benign solitary pulmonary nodules: a meta-analysis.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014Pooled it
- Ultralow dose CT for follow-up of solid pulmonary nodules: A pilot single-center study using Bland-Altman analysis.Medicine · 2018Trial
- Characterization of Individuals Taking Part in Low Dose Computed Tomography (LDCT) Screening Program.Pathology oncology research : POR · 2015Trial
- Prediction of Histological Subtype Based on Segmental Localization of Malignant Pulmonary Nodule in the Upper Lobe of the Lung.Thoracic cancer · 2026Article
- Ultra-low-dose chest computed tomography with model-based iterative reconstruction in the analysis of solid pulmonary nodules: A prospective study.World journal of radiology · 2024Article
- Systematic Review of Lung Cancer Screening: Advancements and Strategies for Implementation.Healthcare (Basel, Switzerland) · 2023Review
- Complications and diagnostic accuracy of CT-guided 18G tru-cut versus end-cut percutaneous core needle biopsy of solitary solid lung nodules.Diagnostic and interventional radiology (Ankara, Turkey) · 2022Article
- Estimation of Preclinical State Onset Age and Sojourn Time for Heavy Smokers in Lung Cancer.Statistics and its interface · 2022Article
- Radiation Therapy Planning of Thoracic Tumors: A Review of Challenges Associated With Lung Toxicities and Potential Perspectives of Gallium-68 Lung PET/CT Imaging.Frontiers in medicine · 2021Review
- Article
- Identification of lung cancer gene markers through kernel maximum mean discrepancy and information entropy.BMC medical genomics · 2019Article
- Solitary peribronchiolar metaplasia showing a sub-solid nodule on computed tomography.General thoracic and cardiovascular surgery · 2019Article
- Racial Differences in Smoking-related Disease Risk Perceptions Among Adults Completing Lung Cancer Screening: Follow-up Results from the ACRIN/NLST Ancillary Study.Journal of racial and ethnic health disparities · 2019Article
- Stereotactic Body Radiotherapy for Early-Stage Multiple Primary Lung Cancers.Clinical lung cancer · 2019Article
- Non-intubated thoracoscopic surgery for lung cancer in patients with impaired pulmonary function.Annals of translational medicine · 2019Article
- Health-related quality of life and anxiety in the PAN-CAN lung cancer screening cohort.BMJ open · 2019Article
- Novel non-invasive early detection of lung cancer using liquid immunobiopsy metabolic activity profiles.Cancer immunology, immunotherapy : CII · 2018Article
- Population impact of lung cancer screening in the United States: Projections from a microsimulation model.PLoS medicine · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Screening using low-dose computed tomography (CT) represents an exciting new development in the struggle to improve outcomes for people with lung cancer. Randomised controlled evidence demonstrating a 20% relative lung cancer mortality benefit has led to endorsement of screening by several expert bodies in the US and funding by healthcare providers. Despite this pivotal result, many questions remain regarding technical and logistical aspects of screening, cost-effectiveness and generalizability to other settings. This review discusses the rationale behind screening, the results of on-going trials, potential harms of screening and current knowledge gaps.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.